Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Gückenberger(University Hospital of Zurich), Piet Ost(Ghent University Hospital), Anne‐Marie C. Dingemans(Erasmus MC Cancer Institute), Bertrand Tombal(Cliniques Universitaires Saint-Luc), Yolande Lievens(Ghent University Hospital), Frédéric Lecouvet(Cliniques Universitaires Saint-Luc), Angelique B. Bouma(European Organisation for Research and Treatment of Cancer), Nandita M. deSouza(Royal Marsden NHS Foundation Trust), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Daniel H. Schanne(University of Zurich), Coen Hurkmans(Radboud University Nijmegen), Laurence Collette(GlaxoSmithKline (Belgium)), Marta Scorsetti(Humanitas University), Alejandra Romero(Erasmus MC), Dirk Verellen(University of Antwerp), Icro Meattini(Azienda Ospedaliero-Universitaria Careggi), Christine Verfaillie(European Society for Therapeutic Radiology and Oncology), Nicola S. Russell(The Netherlands Cancer Institute), Béatrice Fournier(European Organisation for Research and Treatment of Cancer), André Dekker(Maastricht University Medical Centre)
Cited by 1,055
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k